Alphatec Holdings, Inc.ATECEarnings & Financial Report
Alphatec Holdings, Inc. is a global medical technology company specializing in spinal surgery solutions. It designs, develops and markets spinal implants, surgical instruments and digital surgery platforms for orthopedic and neurosurgical procedures, serving providers across North America, Europe and core Asia-Pacific markets, addressing degeneration, deformity and trauma spinal pathologies.
Revenue
$169.2M
Gross Profit
$116.0M
Operating Profit
$-44.3M
Net Profit
$-51.9M
Gross Margin
68.6%
Operating Margin
-26.2%
Net Margin
-30.7%
YoY Growth
22.2%
EPS
$-0.35
Alphatec Holdings, Inc. Q1 FY2025 Financial Summary
Alphatec Holdings, Inc. reported revenue of $169.2M (up 22.2% YoY) for Q1 FY2025, with a net profit of $-51.9M (down 7.0% YoY) (-30.7% margin). Cost of goods sold was $53.2M, operating expenses totaled $160.3M.
Key Financial Metrics
| Total Revenue | $169.2M |
|---|---|
| Net Profit | $-51.9M |
| Gross Margin | 68.6% |
| Operating Margin | -26.2% |
| Report Period | Q1 FY2025 |
Alphatec Holdings, Inc. Annual Revenue by Year
Alphatec Holdings, Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $764.2M).
| Year | Annual Revenue |
|---|---|
| 2025 | $764.2M |
| 2024 | $611.6M |
| 2023 | $482.3M |
| 2022 | $350.9M |
Alphatec Holdings, Inc. Quarterly Revenue & Net Profit History
Alphatec Holdings, Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $212.9M | +20.4% | $-21.7M | -10.2% |
| Q3 FY2025 | $196.5M | +30.4% | $-28.6M | -14.5% |
| Q2 FY2025 | $185.5M | +27.5% | $-41.1M | -22.2% |
| Q1 FY2025 | $169.2M | +22.2% | $-51.9M | -30.7% |
| Q4 FY2024 | $176.8M | +28.1% | $-33.3M | -18.9% |
| Q3 FY2024 | $150.7M | +27.4% | $-39.6M | -26.3% |
| Q2 FY2024 | $145.6M | +24.5% | $-40.7M | -27.9% |
| Q1 FY2024 | $138.5M | +26.9% | $-48.5M | -35.0% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $138.5M | $145.6M | $150.7M | $176.8M | $169.2M | $185.5M | $196.5M | $212.9M |
| YoY Growth | 26.9% | 24.5% | 27.4% | 28.1% | 22.2% | 27.5% | 30.4% | 20.4% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $774.6M | $768.6M | $745.9M | $775.7M | $785.5M | $790.3M | $787.2M | $791.2M |
| Liabilities | $737.0M | $751.5M | $747.3M | $789.9M | $871.4M | $766.5M | $775.7M | $778.8M |
| Equity | $37.6M | $17.1M | $-1.4M | $-14.2M | $-85.9M | $23.8M | $11.5M | $12.4M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-38.4M | $-11.4M | $-5.3M | $10.5M | $-5.0M | $15.5M | $14.0M | $20.7M |